Jubilant Pharmova’s step down subsidiary — Jubilant Pharma Holdings Inc (JPHI) has entered into loan agreement with Standard Chartered Bank. The agreement is for five year loan facility for repayment of existing term loan and bonds aggregating $350 million and additional tranche of $50 million for future growth capex.
Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.